Motus GI said this week it intends to hold an initial public offering to raise approximately $28.8 million, according to an SEC filing. The company developed and produces the Pure-Vu cleaning system which is designed to be used with a standard colonoscope to perform intra-procedural cleaning of poorly prepared colons. Motus GI won FDA clearance for […]
MOTUS GI
Motus GI raises $30m for Pure-Vu colonoscopy system
Motus GI said today that it closed a $30 million private placement which it plans to use in support of the commercial launch of its Pure-Vu colonoscopy system. The lead investor in the placement was Perceptive Advisors, joined by Orchestra Medical Ventures, Ascent Biomedical Ventures, Jacobs Investment Company, GJG Life Sciences and Pura Vida Investments. The […]
Motus GI raises $26m in new offering
Motus GI raised $25.6 million in a new offering, with 171 investors contributing to the round, according to regulatory filings. The Tirat Carmel, Israel-based company said it still has $4.4 million left to raise. Although the company has not made a formal statement detailing how it plans to spend its newly-acquired funds, it wrote in an SEC […]
Siemens US CEO Spiegel to step down, Marks & Davis step up | Personnel Moves November 30, 2016
Siemens (NYSE:SI) said today that its U.S. CEO Eric Spiegel is retiring at the end of the year, with Lisa Davis slated to take the role of chair & CEO of the US-based Siemens Corporation, while Judith Marks will act as Siemens CEO U.S. Both changes are slated to go into effect January 1, 2017, according […]
Motus GI touts Pure-Vu clinical data
Despite a 24-hour liquid diet and a purgative to clean the bowels to prepare for a colonoscopy, patients are poorly prepped in 20% of the 15 million colonoscopies performed worldwide each year, according to Motus GI CEO Mark Pomeranz. This can mean that patients need to return for a 2nd visit and doctors can miss cancerous lesions. […]